Strong evidence suggest that FFAR2 acts a colon tumor suppressor and its deficiency has been associated with an enhanced downstream cAMP–PKA–CREB pathway, which resulted in epigenetically decreased levels of inflammation suppressors [28] or the activation of the Wnt pathway [24]. This evidence concerns the gene FFAR2 and colonic neoplasm.